Dimerix Bioscience Pty Ltd.

Dimerix Bioscience Pty Ltd is a biotechnology company specializing in discovering and developing new treatments for chronic diseases. Their innovative drug discovery platform enables the identification of potential drug candidates for a variety of conditions, including diabetic kidney disease and focal segmental glomerulosclerosis. With a focus on personalized medicine, Dimerix aims to improve patient outcomes through targeted therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#29 in Victoria

#554 in Australia

Victoria, Australia

Dimerix Bioscience Pty Ltd.

Forward Citations = 7

9 inventors:

Kevin D G Pfleger (5 out of 5 patents)

Elizabeth McCall (5 out of 5 patents)

James Williams (5 out of 6 patents)

4. Ruth Marie Seeber (2 out of 2 patents)

5. Karin Ann Eidne (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dimerix Bioscience Pty Ltd.. Retrieved from https://idiyas.com/company/dimerix-bioscience-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]